Elanco Animal Health Inc (ELAN)
13.31
-0.15
(-1.11%)
USD |
NYSE |
Apr 24, 16:00
13.30
0.00 (0.00%)
Pre-Market: 20:00
Elanco Animal Health Cash from Investing (TTM): -169.00M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -169.00M |
September 30, 2023 | -210.00M |
June 30, 2023 | -211.00M |
March 31, 2023 | -205.00M |
December 31, 2022 | -179.00M |
September 30, 2022 | -177.00M |
June 30, 2022 | -581.00M |
March 31, 2022 | -569.00M |
December 31, 2021 | -530.00M |
September 30, 2021 | -530.00M |
June 30, 2021 | -4.785B |
Date | Value |
---|---|
March 31, 2021 | -4.749B |
December 31, 2020 | -4.779B |
September 30, 2020 | -4.780B |
June 30, 2020 | -166.50M |
March 31, 2020 | -224.00M |
December 31, 2019 | -235.00M |
September 30, 2019 | -208.60M |
June 30, 2019 | -147.00M |
March 31, 2019 | -123.60M |
December 31, 2018 | -127.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-4.785B
Minimum
Jun 2021
-147.00M
Maximum
Jun 2019
-1.233B
Average
-224.00M
Median
Mar 2020
Cash from Investing (TTM) Benchmarks
Merck & Co Inc | -14.08B |
Catalent Inc | -410.00M |
NanoString Technologies Inc | 90.30M |
Cytokinetics Inc | 239.25M |
Geron Corp | -180.32M |